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The long-term consumption of cassava (Manihot esculenta Crantz) juice produce neurotoxic
effects in the rat, characterized by an increased motor activity in the open ﬁeld test and
presence of uncoordinated swim (i.e., lateral swimming), in the swim test; which has
been associated with damage in the hippocampus (CA1). On the other hand, ﬂavonoids
content in the Ginkgo biloba extract has been reported to produces neuroprotective effects
at experimental level; therefore we hypothesized that G. biloba extract may prevents the
motor alterations produced by cassava juice and reduce cellular damage in hippocampal
neurons of the rat. In present study the effect of vehicle, cassava juice (linamarin,
0.30 mg/kg), G. biloba extract (dry extract, 160 mg/kg), and combination of treatment
were evaluated in the open ﬁeld and swim tests to identify locomotor and hippocampal
alterations in adult maleWistar rats. All treatments were administered once per day, every
24 h, for 28 days, by oral rout. The effect was evaluated at 0, 7, 14, 21, and 28 days
of treatment. The results show that cassava group from day 14 of treatment increase
crossing and rearing in the open ﬁeld test, as compared with the vehicle group; while
in the swim test produces an uncoordinated swim characterized by the lateral swim. In
this same group an increase in the number of damage neurons in the hippocampus (CA1)
was identiﬁed. Interestingly, both behavioral and neuronal alterations produced by cassava
juice administration were prevented by treatment with G. biloba extract.The results shown
that G. biloba extract exert a protective effect against behavioral and neuronal damage
associated with consumption of cassava juice in the rat. These effects are possibly related
with ﬂavonoid content in the G. biloba extract.
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INTRODUCTION
One of the main food for human beings are tubers and roots, due
to its simplicity of production, easy storage of their derivates and
the relative stability of the chemical compounds. The potato and
cassava are the most important edible tubers because of its high
carbohydrate content. Cassava root is usually consumed fresh,
or processed as ﬂour, some populations of Africa and America
also consume leaves due to its medicinal properties (FAO and
WHO, 2009; Rivadeneyra-Domínguez et al., 2013). However, cas-
sava contains cyanogenic glycosides (linamarin and lotaustralin)
which through hydrolysis produce cyanohydrin and glucose, and
it is metabolized into acetone and hydrocyanic acid free. This
metabolic process produces toxicity in the organism when it
reaches concentrations above 100 μg (Ceballos and de la Cruz,
2002; Sornyotha et al., 2007).
Excessive consumption of cassava, an inappropriate processing
and a low protein diet has been associated with neurodegenera-
tive and neurological diseases such as lathyrism, hypothyroidism,
Konzo, and Tropical Ataxic Neuropathy (TAN; Zaninovic, 2003;
FAOandWHO,2009). Furthermore, has been reported signiﬁcant
damage in brain structures involved in motor and cognitive inte-
gration including thalamic nuclei, piriform cortex, ventral nuclei,
paraventricular area, and hippocampus, among others. In a pre-
vious study, Rivadeneyra-Domínguez et al. (2013) was reported
that treated rats with cassava juice, in which linamarin was identi-
ﬁed, shown alterations in motor incoordination (i.e., an increase
in the lateral swimming) when they were evaluated to the swim
test; which evidenced the neurotoxic effects associated probably
with linamarin contained in the cassava juice.
On the other hand, Ginkgo biloba contains bioactive con-
stituents mainly ﬂavonoids (i.e., quercetin, kaempferol, and
isorhamnetin), some diterpene trilactones such as ginkgolide A,
B, and C sesquiterpene trilactonic, bilobalide, and proanthocyani-
dins (Koltermann et al., 2007), among others. Kaempferol and
quercetin contained in G. biloba extracts are involved in the neu-
roprotective effects identiﬁed in vivo studies. Also it has been
found that the neuroprotective effect of G. biloba extracts against
excitotoxicity-induced damage associated with the overactivation
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of N-methyl-D-aspartate receptors, is associated with the high
content of ﬂavonoids and some sesquiterpenelactones. Addi-
tionally, ﬂavonoids possess antioxidant activity, inhibiting the
formation of hydroxyl and adriamicil radicals; reducing the lipid
peroxidation (Pincemail et al., 1989; Filoteo et al., 1997; Xiao et al.,
2006).
Ginkgo biloba extract also reduces neuroinﬂammation process;
improves memory, learning, and cognitive function through a
lower loss of muscarinic and α-adrenergic receptors. Additionally,
G. biloba extracts increase the levels of choline acetyltransferase
and somatostatin, in the cerebral cortex and some hippocam-
pus regions (Tang et al., 2002; Spencer, 2009). Because G. biloba
extract may exert neuroprotective effects in some brain structures,
including hippocampus (Ying-Shan et al., 2000; Ahlemeyer and
Krieglstein, 2003), and long-term consumption of cassava juice
(Manihot esculentaCrantz) producesmotor incoordination appar-
ently associated with neurotoxic effects of linamarin contained in
it, we hypothesized that the treatment with a G. biloba extract
prevents motor incoordination in rats subjected to the swim test,
and additionally reduces the neuronal damage in the hippocampus
CA1 area.
MATERIALS AND METHODS
BIOLOGICAL MATERIAL
Cassava tubers (M. esculenta Crantz), free of agrochemicals, were
collected from a traditional cultivation in the town of Defensa,
Yecuatla county, Veracruz State, México (latitude19◦ 52′00′′ N,
longitude 96◦47′00′′ W) at an altitude 260 m above sea level
(INEGI, 2010). The biological material was authenticated by
professional staff who specialize in taxonomy from the Herbar-
ium XAL at the Institute of Ecology A.C. (INECOL) in Xalapa,
Veracruz, México.
CASSAVA JUICE
Preparation cassava juice was performed according to proce-
dures described in previous studies (Rivadeneyra-Domínguez
et al., 2013). To avoid any degradation process, the cassava juice
was freshly prepared every day before administration. Tubers were
washed just after collection. Theywere peeled and cut into approx-
imately 5 cm × 2 cm × 2 cm pieces. To standardize and facilitate
the doses administered, the juice of the tuber was obtained with
a juice extractor machine (Moulinex Model Centri III, Celaya,
Guanajuato, México) and immediately administered per os to the
rats.
STANDARDIZED EXTRACT OF Ginkgo biloba
Dry standardized extract of G. biloba (Pharmaceutical presenta-
tion, VASODIL®, Laboratorios ALTANA Pharma, México) was
used. It contains dry extract of G. biloba 40 mg/mL and 9.6 mg
of standardized ﬂavones glycosides calculated as quercetin and
kaempferol. The used dose in present investigation was 160 mg/Kg
of the rats’ weight.
ANIMALS, EXPERIMENTAL GROUPS, AND TREATMENTS
Thirty-two adult male Wistar rats, weighing 250–300 g, were
obtained from the vivariumof the Facultad deMedicina,Universi-
dad Veracruzana, Xalapa, Veracruz, México. The rats were housed
eight per cage in Plexiglas cages, with a 12 h/12 h light/dark cycle
(lights on at 7:00AM) and average room temperature of 25 ± 1◦C.
The animals had ad libitum access to water and food. All of the
experimental procedures were performed according to the Guide
for the Care and Use of Laboratory Animals (National Research
Council, 1996) and the Norma Oﬁcial Mexicana para el Uso y
Cuidado de Animales de Laboratorio (Norma Oﬁcial Mexicana,
NOM-062-ZOO, 1999). All efforts were made to minimize animal
discomfort during the course of this investigation.
A longitudinal study with four independent groups (n = 8
rats per group) was performed: a control group received vehicle
of G. biloba extract plus vehicle of cassava juice, a second group
received vehicle of G. biloba extract plus cassava juice, a third group
received G. biloba extract plus vehicle of cassava juice, and the last
group received G. biloba extract plus cassava juice. The vehicle
or the extract of G. biloba was administered in an equivalent vol-
ume of 2 mL/Kg of the rats’ weights by oral rout (PO); containing
160 mg/2 mL of standardized extract of G. biloba. The vehicle
or the juice of cassava was administered 30 min after adminis-
tration of vehicle or extract of G. biloba, by PO in an equivalent
volume of 2 mL/Kg of the rats’ weights, containing 0.30 mg of
linamarin per 2 mL of cassava juice. All of the treatments were
administered once per day, every 24 h, for 28 days through a dis-
placeable sterilized intraesophageal polyethylene cannula (4 cm
length, 1.0 mm diameter; S-54-HLCole-Parmer, Vernon Hills, IL,
USA) coupled to a disposable syringe (Roger, Chalco, Estado
de México, México). In the baseline session (day 0) without
treatment, the rats were evaluated in the open ﬁeld test and sub-
sequently swim test. At the end of this ﬁrst session, the treatments
began. One hour after vehicle or cassava juice administration on
days 7, 14, 21, and 28 of treatment, the rats were evaluated in the
same behavioral tests. After the last swim test (day 28) the rats
were perfused and the brains removed for subsequent histological
analysis.
BEHAVIORAL TESTS
All of the open ﬁeld and swim test sessions were video-recorded.
Two independent observers who were blinded to the treatments
recorded the dependent variables using custom-designed software
until they attained results with a conﬁdence index of at least 95%.
OPEN FIELD TEST
The rats were individually placed in an opaque Plexiglas cage
(44 cm × 33 cm) with 20 cm high walls and the ﬂoor divided
into 12 squares (11 cm × 11 cm). The number of crossings and
rearings were recorded during a 5 min test. A crossing was scored
when a rat passed from one square to another with its hindlimbs.
A rearing was considered when the rat assumed a vertical posture,
supported by its hindlimbs, with respect to the ﬂoor of the box.
A crossing was interpreted as an indicator of motor activity, and
rearing was used to determine alterations in motor coordination.
The swim test was performed after the open ﬁeld test.
SWIM TEST
The rats were individually placed in a rectangular pool
(26 cm × 29 cm × 50 cm) ﬁlled with water (25 ± 1◦C), for
5 min. The depth of the water was adjusted so that the rat could
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touch the bottom of the pool with one or both of its hindlimbs
and tail. At the beginning of the test, the rat was gently placed
in one corner of the pool. The rats swam vigorously as soon as
they contacted the water. None of the animals drowned. After
this initial swimming behavior, the rats displayed lateral swim-
ming as previously was described (Rivadeneyra-Domínguez et al.,
2013). The dependent variablewas the number of times that lateral
swimming was displayed by the rat in this test. Lateral swim-
ming is operationally deﬁned as behavior in which the rat swims
slowly on its side without maintaining its horizontal balance. Dur-
ing this behavior, the rat swims on its right or left side, with its
head maintained horizontally. The hindlimbs remain extended
and rigid, parallel to the water surface, for short periods of time.
The hindlimbs are uncoordinatedly moved to achieve water dis-
placement. One or both forelimbs remain retracted. After this
lateral swimming, the rats eventually swim “normally” for short
periods of time.
HISTOLOGICAL ANALYSIS
Perfusion
At the end of behavioral tests (day 28 of treatment), the rats
received an overdose of sodium pentobarbital (Sedalphorte®, Lab-
oratorios Salud y bienestar animal, México) and were perfused
transcardially with 200 mL of saline solution followed by 200 mL
of 4% paraformaldehyde in 0.1 M phosphate buffer (Tempera-
ture 27◦C, pH 8.3). The brains were removed and preserved in
20% formalin until histological analysis.
Dehydration brain
The brains were dehydrated in ethanol solutions (70, 80, 96, and
100%), cleared in xylene and embedded in parafﬁn. Serial coronal
sections of 10 μm thick-sections at the level of the hippocampus:
interaural 4.70 mm, Bregma 4.30 mm (Paxinos andWatson, 1998)
were obtained with a vibratome.
Stains and preparation of brain slices
The brain slices containing the hippocampus were stained with
the modiﬁed technique of hematoxylin–eosin and dried at room
temperature (Lynch et al., 1982; Neira and Sedano, 2008). Poste-
riorly, the stained brain slices were mounted with Permount for
analysis by light microscopy.
Quantiﬁcation of damaged cells
Three ﬁelds of different slices that included the CA1 area of the
right (Ap = −3.30 to −4.00 mm, L = 1.2 mm and H = 3.0 mm)
or left (Ap = 3.30 to –4.00 mm, L = −1.2 mm, and H = 3.0 mm)
hippocampus with respect to Bregma (Paxinos and Watson, 1998)
were analyzed per rat from each group. The number of dam-
aged cells in each experimental group was measured. Neuronal
damage was considered when under optical microscope exam-
ination the presence of eosinophilic neurons (acidophilic) with
nuclear changes characterized by the presence of eosinophilic
cytosol and pyknotic or fragmented nuclei were identiﬁed; which
are indicators of neuronal damage (Neira and Sedano, 2008).
Statistical analysis
The data from two behavioral tests were analyzed by two-way
ANOVA, considering as the ﬁrst factor treatment, and the second
factor days of treatment. Signiﬁcant differences (p ≤ 0.05) in the
ANOVA were followed by Student-Newman-Keuls post hoc test.
The data from the histological study were analyzed using Kruskal–
Wallis one-way ANOVA on Ranks, followed by Tukey post hoc test.
All data are expressed as the mean ± SE for each variable.
RESULTS
LOCOMOTOR ACTIVITY IN THE OPEN FIELD TEST
Table 1 shows the results of crossing in the open ﬁeld test
in rats treated with vehicles, cassava juice, G. biloba, or com-
bination of treatments (G. biloba plus cassava juice). The
analysis of crossing show signiﬁcant differences among treat-
ments [F(3,140) = 19.778; p < 0.001], days of treatment
[F(4,140) = 10.610; p < 0.001], and interaction between
factors [F(12,140) = 2.344; p < 0.009]. The post hoc test
showed that the vehicle and G. biloba treated groups reduce
signiﬁcantly the crossing throughout the experimental sessions.
However, in the cassava treated group crossing was reduced
in days 7 and 14 of treatment respect to the vehicle treated
group, but it was recovered to basal values in days 21 and
28 of treatment. No signiﬁcant differences were detected in
the G. biloba plus cassava juice treated groups along of the
experiment.
The analysis of the rearing showed similar results to those
obtained in crossing in the open ﬁeld test; that behavior was
affected by treatments [F(3,140) = 13.642; p < 0.001], days of
treatment [F(4,140) = 4.712; p < 0.001], but not interaction
between factors [F(12,140) = 1.540; p = 0.117] was identiﬁed.
The post hoc test revealed that the control, G. biloba or G. biloba
plus cassava juice groups reduced rearing from day 14 of the treat-
ment until the end of the study, while the group receiving cassava
Table 1 | Number of crossing in the open field test along of days of treatments.
Treatment Basal Day 7 Day 14 Day 21 Day 28
Control 44.5 ± 9.8 37.6 ± 8.7* 24.5 ± 3.57* 14.0 ± 4.49* 16.25 ± 2.5*
Cassava juice 44.5 ± 9.8 28.6 ± 4.1 29.1 ± 7.8 36.75 ± 5.1+ 42 ± 2.1+
Ginkgo biloba 44.5 ± 9.8 17.3 ± 3.8* 19.6 ± 4.5* 8.0 ± 1.9* 11.0 ± 3.3*
Cassava juice + Ginkgo biloba 44.5 ± 9.8 14.1 ± 3.4 13.5 ± 2.4 11.0 ± 2.0 16.13 ± 2.3
The values represent the mean ± SE of eight rats. *p < 0.05 vs basal of the same group; +p < 0.05 vs. all groups in the same day of treatment (two-way ANOVA,
post hoc test Student-Newman-Keuls).
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FIGURE 1 | Number of rearing in the open field test. All experimental
groups, except cassava juice group reduced rearing from day 14 of
treatment respect to the basal values of the same group. *p < 0.05 vs all
groups in the same day of treatment. (two-way ANOVA, post hoc test
Student-Newman-Keuls)
juice treatment reduced rearing on day 7 days of treatment com-
pared to the basal; but it was recovered to the basal values from
day 14 of treatment (Figure 1).
SWIM TEST
The analysis of the number of lateral swim showed signiﬁ-
cant differences considering treatments [F(3,149) = 237.654;
p < 0.001], days of treatments [F(4,149) = 24.256; p < 0.001],
and in the interaction of factors [F(12,149) = 24.332;
p < 0.001]. The post hoc test revealed that rats control or
treated with G. biloba did not presented lateral swimming
along of the days of treatment. However, rats that consume
cassava juice showed an increase in the number of lateral
swim from day 7 of treatment and this effect being more
accentuated at 28 day of treatment. Interestingly, this effect
was no detected in the G. biloba plus cassava juice group
(Figure 2).
DAMAGED NEURONS IN CA1 AREA OF THE HIPPOCAMPUS
Figure 3 show a representative photograph of CA1 hippocam-
pus damage neurons in each treatment group. The anal-
ysis of the damage neurons in this area did not revealed
signiﬁcant differences among left or right side, therefore
all neurons were including together as CA1 hippocampus
area. The analysis of the number of damaged neu-
rons in the CA1 area of hippocampus from differ-
ent groups of treatment showed signiﬁcant differences
[H(3) = 26.121; p < 0.001]. The post hoc test showed
that cassava juice-treated group had the higher number
(13.75 ± 1.90) of damaged neurons (p < 0.05), as com-
pared with the others groups: control (0.50 ± 0.18),
G. biloba (0.62 ± 0.18) and G. biloba plus cassava juice
(3.00 ± 0.46). As showed the results G. biloba treatment
prevents the neuronal damage associated with cassava juice
treatment.
FIGURE 2 | Number of lateral swim.This behavior was only detected in
the cassava juice treated group, an effect prevented by simultaneous
administration of Ginkgo biloba extract. *p < 0.05 vs basal and all groups in
the same day of treatment. (two-way ANOVA, post hoc test
Student-Newman-Keuls).
FIGURE 3 | Representative photography of hippocampus neurons
(CA1) corresponding to each treatments.The higher number of damage
neurons was detected in cassava group, in which also a reduced number of
neurons was observed compared with the other groups of treatment. Black
arrow indicates hippocampus damaged neurons.
DISCUSSION
The open ﬁeld test is widely used to detect changes in locomo-
tor activity, associated with experimental manipulations or drug
administrations (i.e., hyperactivity, hypoactivity, or not changes
associated with drug treatment). Repeated session in the open
ﬁeld test induces habituation in the animals, reducing crossing in
subsequently session respect to basal session (Brudzynski andKrol,
1997). In the present study, the control, G. biloba, and G. biloba
plus cassava juice groups, decreased locomotor activity in the open
ﬁeld along the experimental sessions, which is in accordance with
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previous reports (Spencer, 2009), considering the common habit-
uation to this test after repeated sessions. Contrarily, the cassava
juice group initially reduced crossing, but from day 14 of treat-
ment crossing returned to basal values, which could be related
with the neurotoxic effects produced by linamarin contained in
the cassava juice as previously reported (Rivadeneyra-Domínguez
et al., 2013). The fact that the G. biloba plus cassava juice group
had a gradual reduction of crossing along of the experiment sim-
ilarly to the control group, suggest a protective effect of G. biloba
extract against the toxic effects produced by cassava juice iden-
tiﬁed by changes on the motor activity. Present result may be
supported by the neuroprotective effects of G. biloba extracts pre-
viously reported (Pincemail et al., 1989; Filoteo et al., 1997; Xiao
et al., 2006; Spencer, 2009). Respect to rearing in the open ﬁeld
also was gradually reduced along of experimental session as previ-
ous reports (Rivadeneyra-Domínguez et al., 2009, 2013; Saavedra
et al., 2011), which is associated with an adaptive effect by the
repetition of the test. However, rats treated with cassava juice
on day 21 and 28 of treatment increasing this behavior respect
to the other experimental groups. This effect support the motor
alterations in the cassava treated group, and the protective effect
of G. biloba, considering that group with the extract of this
plant plus cassava juice did not increase rearing as cassava juice
do it.
In present investigation, cassava juice treatment produced loco-
motor incoordination in the swim test, represented by lateral
swimming. In a previous study was reported that long-term con-
sumption of cassava juice (Rivadeneyra-Domínguez et al., 2013)
or Dioon spinulosum seeds, induced motor alterations charac-
terized by lateral swimming or rotational behavior in the swim
test (Rivadeneyra-Domínguez et al., 2009) which was associated
with the content of linamarin or neurotoxicmethylazoxymethanol
(MAM), respectively. Interestingly, when MAM was microinjected
into the hippocampal (CA1) of the rat, a motor incoordination in
the swim test was observed (Saavedra et al., 2011). These results,
shown that hippocampus participate in the locomotor alterations
induced by neurotoxic compounds of some plants.
Among the diseases associated with cassava consumption are
TAN and Konzo, which are mainly characterized by paraparesis
of the lower or upper extremities, ataxia, muscle weakness, and
motor alterations (Tylleskär, 1994; Peterson et al., 1995; Zaninovic,
2003; FAO and WHO, 2009). Therefore it could be related with
motor alterations observed in rats treatedwith cassava juice; which
was prevented by coadministration of G. biloba extract in present
investigation. We report a toxic effect on motor activity in rats
treated with cassava juice and is suggested that this effect could be
related with chemical compounds contained in the plant; however
it is necessary to realize additional speciﬁc studies to identify or
discard other toxics effect on muscle stiffness, respiratory, cardio-
vascular, digestive, metabolic systems and cancer that could occur
under long-term cassava consumption.
Previous studies have reported that G. biloba extract reduces
neuronal damage caused by intoxication with methyl parathion
and preserve cellular organization of the cerebellum granular layer
in the rat (Cárdenas et al., 2010). In present study cassava juice
group had a high number of damaged cells in the hippocam-
pus (CA1), which was not detected in G. biloba plus cassava
juice group. Aforementioned, suggests a neuroprotective effect
of G. biloba extract on hippocampal neurons, probably associated
with a reduction of excitotoxicity on NMDA receptors; however,
speciﬁc studies are required to clarify this propose. The effect of
ﬂavonoids on the brain and cellular function include neuropro-
tection, reduction of neuroinﬂammation and improve memory,
learning, and cognitive function (Mu et al., 2007). Additionally,
ﬂavonoids contribute to permeability, nutrition, oxygen uptake,
and ATP synthesis (Mahadevan and Park, 2008). Flavonoids from
G. biloba extract produces antioxidant activity and neutralizes free
oxygen and hydroxyl radicals increased during cerebral damage
followed of the ischemia (Blecharz-Klin et al., 2009). Although
present study did not explored the cellular mechanism involved in
the hippocampal neuronal damage produced by cassava juice nor
the apparent protective effect of the G. biloba extract, the results
suggests that evaluated extract produces a neuroprotective effect in
hippocampal cells against toxic compounds contained in cassava
juice, which must be explored in future studies. However present
results, suggest that hippocampus could participate inmotor alter-
ations detected in cassava treated group, which may be support by
previous studies in which microinjection of neurotoxic chemical
compounds isolated from cycads (Saavedra et al., 2011), produces
motor alterations in the rat, similar to detected in cassava treated
rats.
Finally, although the precise mechanisms underlying the pro-
tective effect of G. biloba extract has not been explored in this
study, it may be associated with the ﬂavonoid content in the G.
biloba extract (Ahlemeyer and Krieglstein, 2003). In this way, there
is evidence that ﬂavonoids content in theG. biloba extractmay pre-
vent excitotoxicity induced by NMDA receptor stimulation. This
is relevant, considering that some toxic compounds contained
in cassava juice can contribute to the overactivation of NMDA
receptors (Spencer, 2009), causing neurotoxic effect. Therefore, it
suggests that G. biloba extract may have protective activity against
toxic effects produced by chemical compounds contained in cas-
sava juice and consequently prevents locomotion impairments in
the rats.
CONCLUSION
The long-term consumption of cassava juice produced locomo-
tion impairment probably associated with neuronal damage in
the hippocampus (CA1), which is attenuated by G. biloba extract
in Wistar rats.
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